Science Explorer Back to mapMap
Discussion
Researcher · Karl Landsteiner Society · Austria

Hannah Fabikan

Hannah Fabikan publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Surgery, on topics such as Lung Cancer Treatments and Mutations, Lung Cancer Research Studies and Lung Cancer Diagnosis and Treatment.

OpenAlex
World rank
#2,219,515
of 7,710,434 ranked researchers
Rank in Austria
#13,384
of 43,330
Works
39
Citations
361
Citations per work
9.3
h-index
10
i10-index 10Top 52% in Pulmonary and Respiratory Medicine
Hannah Fabikan

What does Hannah Fabikan research?

Hannah Fabikan's work is mostly in Medicine (83%), Biochemistry, Genetics and Molecular Biology (8%).

Health Sciences: 32 works · 82.9% of their workMedicine: 32 works · 82.9% of their workPulmonary and Respiratory Medicine: 17 works · 43.6% of their workOncology: 12 works · 31.6% of their workSurgery: 2 works · 4.3% of their workGenetics: 1 works · 3.4% of their workEverything else: 4 works · 9.4% of their workLife Sciences: 3 works · 7.7% of their workBiochemistry, Genetics and Molecular Biology: 3 works · 7.7% of their workMolecular Biology: 2 works · 4.3% of their workCancer Research: 1 works · 3.4% of their workTHEIR WORKHannah Fabikan39works
Life Sciences8%Health Sciences83%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine3282.9%
  2. Everything else49.4%
    1. Biochemistry, Genetics and Molecular Biology37.7%
  1. 1Pulmonary and Respiratory Medicine44% of their works
  2. 2Oncology32% of their works
  3. 3Surgery4% of their works
  4. 4Molecular Biology4% of their works
  5. 5Cancer Research3% of their works
  6. 6Genetics3% of their works

Research topics

Which keywords describe Hannah Fabikan's research?

The keywords of their largest research topics: Targeted Therapy, Clinical Trials, Chemotherapy, ALK Inhibitors, EGFR Mutations, Immunotherapy, Prognostic Factors and Genomic Profiles.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 22 words, with their numbers
  1. Targeted Therapy493 topics
  2. Clinical Trials452 topics
  3. Chemotherapy403 topics
  4. ALK Inhibitors261 topic
  5. EGFR Mutations261 topic
  6. Immunotherapy232 topics
  7. Prognostic Factors222 topics
  8. Genomic Profiles191 topic
  9. Small-Cell Lung Cancer191 topic
  10. CT Screening171 topic
  11. Lung Cancer171 topic
  12. Tumor Microenvironment92 topics
  13. Immune Checkpoint Blockade51 topic
  14. PD-1 and PD-L151 topic
  15. Cancer Genomics41 topic
  16. Mutational Signatures41 topic
  17. Pancreatic Cancer41 topic
  18. Surgical Complications41 topic
  19. Chronic Lymphocytic Leukemia31 topic
  20. Genomic Aberrations31 topic
  21. Neuroendocrine Tumors31 topic
  22. Pancreatic Neuroendocrine Tumors31 topic

Where does Hannah Fabikan work?

Hannah Fabikan's main affiliation in the publication record is Karl Landsteiner Society, Austria.

How many publications and citations does Hannah Fabikan have?

OpenAlex counts 39 works and 361 citations for Hannah Fabikan, an h-index of 10, ranking #2,219,515 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Hannah Fabikan. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.